BG62120B1 - Фармацевтични състави за ректално приложение наалкилсулфонамиди - агонисти на 5-нт1 - Google Patents

Фармацевтични състави за ректално приложение наалкилсулфонамиди - агонисти на 5-нт1 Download PDF

Info

Publication number
BG62120B1
BG62120B1 BG99167A BG9916794A BG62120B1 BG 62120 B1 BG62120 B1 BG 62120B1 BG 99167 A BG99167 A BG 99167A BG 9916794 A BG9916794 A BG 9916794A BG 62120 B1 BG62120 B1 BG 62120B1
Authority
BG
Bulgaria
Prior art keywords
pharmaceutical composition
active ingredient
composition according
methyl
pharmaceutically acceptable
Prior art date
Application number
BG99167A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG99167A (bg
Inventor
Nadine Merlet
Isabelle Richard
Isabelle Thielemans
Original Assignee
Laboratoires Glaxo Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Glaxo Sa filed Critical Laboratoires Glaxo Sa
Publication of BG99167A publication Critical patent/BG99167A/bg
Publication of BG62120B1 publication Critical patent/BG62120B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
BG99167A 1992-05-07 1994-11-07 Фармацевтични състави за ректално приложение наалкилсулфонамиди - агонисти на 5-нт1 BG62120B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929209882A GB9209882D0 (en) 1992-05-07 1992-05-07 Compositions
PCT/EP1993/001077 WO1993021916A1 (en) 1992-05-07 1993-05-03 Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration

Publications (2)

Publication Number Publication Date
BG99167A BG99167A (bg) 1995-06-30
BG62120B1 true BG62120B1 (bg) 1999-03-31

Family

ID=10715158

Family Applications (1)

Application Number Title Priority Date Filing Date
BG99167A BG62120B1 (bg) 1992-05-07 1994-11-07 Фармацевтични състави за ректално приложение наалкилсулфонамиди - агонисти на 5-нт1

Country Status (33)

Country Link
US (1) US5705506A (enExample)
EP (1) EP0639072B1 (enExample)
JP (1) JPH07506570A (enExample)
KR (1) KR100253111B1 (enExample)
AT (1) ATE163850T1 (enExample)
AU (1) AU670083B2 (enExample)
BE (1) BE1007024A5 (enExample)
BG (1) BG62120B1 (enExample)
BR (1) BR1100108A (enExample)
CA (1) CA2135179C (enExample)
CH (1) CH685920A5 (enExample)
CY (1) CY2039B1 (enExample)
CZ (1) CZ283512B6 (enExample)
DE (1) DE69317418T2 (enExample)
ES (1) ES2113533T3 (enExample)
FR (1) FR2690847B1 (enExample)
GB (2) GB9209882D0 (enExample)
GR (1) GR3026584T3 (enExample)
HK (1) HK95697A (enExample)
HU (2) HU227338B1 (enExample)
IE (1) IE75203B1 (enExample)
IL (1) IL105468A (enExample)
IT (1) IT1261471B (enExample)
NO (1) NO306700B1 (enExample)
NZ (1) NZ252132A (enExample)
OA (1) OA10109A (enExample)
RO (1) RO112993B1 (enExample)
RU (1) RU2118527C1 (enExample)
SG (1) SG46649A1 (enExample)
TW (1) TW231970B (enExample)
UA (1) UA37206C2 (enExample)
WO (1) WO1993021916A1 (enExample)
ZA (1) ZA933178B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2434297A (en) * 1996-05-23 1997-12-09 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
ME00189B (me) * 1998-03-26 2011-02-10 Astellas Pharma Inc Preparati sa neprekidnim oslobađanjem
AU3731400A (en) * 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Methods and compositions useful in inhibiting apoptosis
AR056690A1 (es) * 2005-10-14 2007-10-17 Athersys Inc Derivados de indol como inhibidores de indol como inhibidores del receptor 3 de histamina para el tartamiento de trastornos del sueno y cognitivos obesidad y otros trastornos de snc
SI2124556T1 (sl) 2006-10-09 2015-01-30 Charleston Laboratories, Inc. Farmacevtske sestave
EP3090743A1 (en) 2008-01-09 2016-11-09 Charleston Laboratories, Inc. Pharmaceutical compositions for treating headache and eliminating nausea
CA2767576C (en) 2009-07-08 2020-03-10 Charleston Laboratories Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
SI2627328T1 (sl) 2010-10-15 2017-01-31 Contera Pharma Aps Kombinacije agonistov receptorjev serotonina za zdravljenje motenj premikanja
CN104411301B (zh) 2012-04-18 2018-02-06 康特拉医药公司 适于改善运动障碍治疗的口服药物配方
CA3055170A1 (en) 2016-03-04 2017-09-08 Charleston Laboratories, Inc. Pharmaceutical compositions
AU2017297718B2 (en) 2016-07-11 2023-06-08 Contera Pharma A/S Pulsatile drug delivery system for treating morning akinesia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE454777B (sv) * 1980-08-12 1988-05-30 Glaxo Group Ltd 5-substituerade 3-aminoalkyl-1h-indoler, forfarande for framstellning av dessa och en farmaceutisk komposition for behandling av migren
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
IT1170387B (it) * 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
GB8332435D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
IT1181741B (it) * 1984-12-04 1987-09-30 Glaxo Group Ltd Derivati di indolo,procedimento per prepararli e composizioni farmaceutiche che li contengono
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
US4833153A (en) * 1985-11-08 1989-05-23 Glaxo Group Limited Indole derivatives
AU611469B2 (en) * 1987-08-13 1991-06-13 Glaxo Group Limited Indole derivatives
PT97888B (pt) * 1990-06-07 1998-12-31 Zeneca Ltd Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem

Also Published As

Publication number Publication date
HU211638A9 (en) 1995-12-28
HK95697A (en) 1997-08-08
EP0639072B1 (en) 1998-03-11
ITRM930286A0 (it) 1993-05-06
RO112993B1 (ro) 1998-03-30
GB9209882D0 (en) 1992-06-24
IL105468A0 (en) 1993-08-18
AU670083B2 (en) 1996-07-04
EP0639072A1 (en) 1995-02-22
WO1993021916A1 (en) 1993-11-11
ITRM930286A1 (it) 1994-11-06
ZA933178B (en) 1994-01-10
HUT71418A (en) 1995-11-28
TW231970B (enExample) 1994-10-11
CH685920A5 (fr) 1995-11-15
GB9309209D0 (en) 1993-06-16
ATE163850T1 (de) 1998-03-15
NO944214L (no) 1994-11-07
OA10109A (en) 1996-12-18
KR100253111B1 (en) 2000-07-01
BE1007024A5 (fr) 1995-02-21
AU4064093A (en) 1993-11-29
DE69317418T2 (de) 1998-07-30
SG46649A1 (en) 1998-02-20
UA37206C2 (uk) 2001-05-15
FR2690847A1 (fr) 1993-11-12
CA2135179A1 (en) 1993-11-11
GR3026584T3 (en) 1998-07-31
US5705506A (en) 1998-01-06
JPH07506570A (ja) 1995-07-20
IE930339A1 (en) 1993-11-17
NO306700B1 (no) 1999-12-13
CZ283512B6 (cs) 1998-04-15
RU2118527C1 (ru) 1998-09-10
HU227338B1 (en) 2011-04-28
DE69317418D1 (de) 1998-04-16
IE75203B1 (en) 1997-08-27
BR1100108A (pt) 1999-12-07
NZ252132A (en) 1996-09-25
GB2266665A (en) 1993-11-10
GB2266665B (en) 1996-05-22
CA2135179C (en) 2000-12-05
ES2113533T3 (es) 1998-05-01
NO944214D0 (no) 1994-11-04
CZ272394A3 (en) 1995-10-18
IL105468A (en) 1998-09-24
FR2690847B1 (fr) 1995-06-09
BG99167A (bg) 1995-06-30
IT1261471B (it) 1996-05-23
CY2039B1 (en) 1998-04-30

Similar Documents

Publication Publication Date Title
JP2000507544A (ja) 痛みの治療方法
BG62120B1 (bg) Фармацевтични състави за ректално приложение наалкилсулфонамиди - агонисти на 5-нт1
RU2308268C2 (ru) Производные арил- или гетероарилазолилкарбинолов для лечения недержания мочи
EA001325B1 (ru) Способы лечения и профилактики интерстициального цистита
JP2965703B2 (ja) 直腸用組成物
AU3810100A (en) Stable pharmaceutical application form for paroxetin anhydrate
KR920703593A (ko) 이미다조퀴녹살린 화합물, 이의 제조방법 및 용도
HK1069530A (en) Aryl (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence